Crinetics Pharmaceuticals, Inc

(NASDAQ:CRNX)

Latest On Crinetics Pharmaceuticals, Inc (CRNX):

Date/Time Type Description Signal Details
2023-05-25 19:43 ESTNewsCrinetics Pharmaceuticals And Its Value Proposition In AcromegalyN/A
2023-05-04 23:54 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43MN/A
2023-03-06 12:48 ESTNewsEvaluating Crinetics' Oral Long Shot For AcromegalyN/A
2023-02-28 18:44 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41MN/A
2022-12-30 22:15 ESTNewsCrinetics: FY23 Could Be Turning Point With Two Phase 3 Acromegaly ReadoutsN/A
2022-11-29 04:07 ESTNewsCrinetics says FDA didn’t clear Phase 2 study request for hyperinsulinism drugN/A
2022-11-15 00:39 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.78 beats by $0.03, revenue of $0.46M beats by $0.26MN/A
2022-08-12 17:31 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28MN/A
2022-06-13 22:31 ESTNewsCrinetics: Late-Stage Acromegaly Disease Studies Will Be Major Inflection PointN/A
2022-05-25 15:30 ESTNewsCrinetics hormone CRN04894 therapy shows promise in early-stage studyN/A
2022-05-13 09:56 ESTNewsCrinetics Pharmaceuticals GAAP EPS of -$0.73 misses by $0.17, revenue of $3.13M misses by $2.07MN/A
2022-04-29 23:10 ESTNewsCrinetics: An Orphan Disease Innovator On The RiseN/A
2022-04-24 11:40 ESTNewsCrinetics Pharmaceuticals: Endocrinology Focus To Pay Off As Multi-Faceted Pipeline Makes ProgressN/A
2022-04-13 16:17 ESTNewsCrinetics Pharmaceuticals prices $125M stock offeringN/A
2022-04-01 04:52 ESTNewsCrinetics stock gains on hyperinsulinism candidate's trial data; JMP raises PTN/A
2022-03-31 09:08 ESTNewsCrinetics Pharmaceuticals reports resultsN/A
2022-03-30 16:39 ESTNewsCrinetics shows dose-dependent effect of hyperinsulinism candidate in early trialN/A
2022-03-18 16:25 ESTNewsCrinetics delays early Phase 1 data for experimental therapy due to COVID-19N/A
2022-02-28 09:07 ESTNewsCrinetics, Sanwa ink licensing deal for cancer/hormonal disorder drug in JapanN/A
2021-10-22 05:14 ESTNewsCrinetics Pharmaceuticals prices $150M in stock offeringN/A
2021-10-21 03:29 ESTNewsCrinetics drops after announcing common stock offeringN/A
2021-09-21 15:29 ESTNewsCrinetics posts preliminary results from early-stage CRN04777 hyperinsulinism studyN/A
2021-09-21 15:23 ESTNewsCrinetics Pharmaceuticals (CRNX) Investor Presentation - SlideshowN/A
2021-09-02 17:30 ESTNewsCrinetics Pharmaceuticals names Jeff Knight as chief operating officerN/A
2021-08-10 23:06 ESTNewsCrinetics Pharmaceuticals posts positive data from early-stage CRN04894 trialN/A
2021-08-10 23:05 ESTNewsCrinetics Pharmaceuticals EPS misses by $0.10N/A
2021-07-29 16:43 ESTNewsCrinetics Pharmaceuticals proposes $15M in private placement with Frazier HealthcareN/A
2021-07-21 02:52 ESTNewsCrinetics doses first patient in late-stage oral paltusotine acromegaly trialN/A
2021-05-07 06:27 ESTNewsCrinetics Pharmaceuticals EPS misses by $0.04N/A
2021-04-08 07:33 ESTNewsCrinetics Pharma raises $75M via equity offeringN/A
2021-03-30 23:41 ESTNewsCrinetics Pharmaceuticals, Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call TranscriptN/A
2021-03-30 23:41 ESTNewsCrinetics Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-01-23 04:21 ESTNewsCrinetics Pharmaceuticals (CRNX) Presents At 39th Annual J.P. Morgan Healthcare Conference - SlideshowN/A
2020-12-13 03:42 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 07:37 ESTAnalyst RatingThe Analyst Target Price has increased from $32.8 to $33.6.Buy
2020-11-09 11:40 ESTFinancialsCompany financials have been released.Neutral
2020-11-09 11:40 ESTEarnings EstimateAn EPS average of -$0.59 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-07 15:30 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 06:16 ESTNewsCrinetics Pharmaceuticals EPS misses by $0.03N/A
2020-10-30 12:37 ESTAnalyst RatingThe Analyst Target Price has decreased from $36.75 to $32.8.Neutral
2020-10-26 14:41 ESTNewsCrinetics Pharma lead drug successful in mid-stage acromegaly studyN/A
2020-09-26 12:27 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-08 04:25 ESTAnalyst RatingThe Analyst Target Price has decreased from $36.8 to $36.75.Neutral
2020-09-05 01:11 ESTNewsCrinetics Pharma to advance ACTH antagonist candidate into the clinicN/A
2020-09-05 00:31 ESTFinancialsCompany financials have been released.Neutral
2020-09-02 11:29 ESTNewsCrinetics Pharmaceuticals- Superior Molecules In EndocrinologyN/A
2020-08-09 08:28 ESTFinancialsCompany financials have been released.Neutral
2020-08-07 16:03 ESTNewsCrinetics Pharmaceuticals EPS beats by $0.02N/A
2020-07-31 00:39 ESTFinancialsCompany financials have been released.Neutral

About Crinetics Pharmaceuticals, Inc (CRNX):

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly and neuroendocrine tumors. The company is also developing CRN01941, an oral selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors; an oral selective nonpeptide somatostatin type 5 receptor agonist for treating congenital hyperinsulinism; and an oral adrenocorticotrophic hormone antagonist for the treatment of cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

See Advanced Chart

General

  • Name Crinetics Pharmaceuticals, Inc
  • Symbol CRNX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 68
  • Fiscal Year EndDecember
  • IPO Date2018-07-18
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.crinetics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 1102.47
  • Price/Book (Most Recent Quarter) 2.99
  • Enterprise Value Revenue 961.96
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.55
  • Operating Margin -17443%
  • Return on Assets -25%
  • Return on Equity -42%
  • Revenue 392000
  • Earnings Per Share -$1.62
  • Revenue Per Share $0.01
  • Gross Profit -40313000
  • Quarterly Earnings Growth -80.7%
View More

Highlights

  • Market Capitalization 531.37 million
  • EBITDA -40113000
  • PE Ratio -16.43
  • Analyst Target Price $33.6
  • Book Value Per Share $5.69
View More

Share Statistics

  • Shares Outstanding 32.92 million
  • Shares Float 20.69 million
  • % Held by Insiders 450%
  • % Held by Institutions 95.14%
  • Shares Short 1.53 million
  • Shares Short Prior Month 1.38 million
  • Short Ratio 13.29
  • Short % of Float 6%
  • Short % of Shares Outstanding 5%
View More

Technicals

  • Beta 1.23
  • 52 Week High $23.7
  • 52 Week Low $11.61
  • 50 Day Moving Average 15.77
  • 200 Day Moving Average 14.69
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Crinetics Pharmaceuticals, Inc (CRNX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Crinetics Pharmaceuticals, Inc (CRNX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-06$N/A-$0.56-$0.53-6.38%
2020-06-302020-08-07$N/A-$0.53-$0.554.21%
2020-03-312020-05-08$N/A-$0.71-$0.63-12.66%
2019-12-312020-03-09$321000-$0.60-$0.6811.35%
2019-09-302019-11-12$505000-$0.60-$0.54-11.92%
2019-06-302019-08-13$N/A-$0.51-$0.46-11.79%
2019-03-312019-05-13$367000-$0.37-$0.394.61%
2018-12-312019-03-13$781000-$0.35-$0.4115.09%
2018-09-302018-11-13$548000-$0.38-$0.34-10.47%
2018-06-302018-08-30$657000-$0.33-$0.31-7.32%

Crinetics Pharmaceuticals, Inc (CRNX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Crinetics Pharmaceuticals, Inc (CRNX) Chart:

Crinetics Pharmaceuticals, Inc (CRNX) News:

Below you will find a list of latest news for Crinetics Pharmaceuticals, Inc (CRNX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Crinetics Pharmaceuticals, Inc (CRNX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-08-15200CALL0 0377.97TRUE00
2025-08-15210CALL0 0341.23TRUE00
2025-08-15220CALL0 0305.57TRUE00
2025-08-15230CALL0 055.16TRUE00
2025-08-15240CALL0 0244.47TRUE00
2025-08-15251.5CALL3 3122.62TRUE1.50
2025-08-15260CALL0 074.55TRUE00
2025-08-15273.4CALL0 291.89FALSE00
2025-08-15285.1CALL0 164.57FALSE00
2025-08-15294.1CALL0 1143.18FALSE00
2025-08-15301.11CALL0 4163.38FALSE00
2025-08-15312.55CALL0 4183.45FALSE00
2025-08-15320.6CALL0 467199.8FALSE00
2025-08-15331.68CALL0 1002216.91FALSE00
2025-08-15340.5CALL0 16187.34FALSE00
2025-08-15350.59CALL0 122174.79FALSE00
2025-08-15361CALL0 3260.02FALSE00
2025-08-15370CALL0 0273.55FALSE00
2025-08-15380CALL0 0153.91FALSE00
2025-08-15390CALL0 0298.79FALSE00
2025-08-15400.2CALL0 6152.8FALSE00
2025-08-15410CALL0 0321.93FALSE00
2025-08-15420CALL0 0332.82FALSE00
2025-08-15430CALL0 0343.31FALSE00
2025-08-15440CALL0 0353.43FALSE00
2025-08-15450CALL0 0363.2FALSE00
2025-08-15460CALL0 0369.95FALSE00
2025-08-15470CALL0 0379.06FALSE00
2025-08-15480CALL0 0387.9FALSE00
2025-08-15490CALL0 0396.48FALSE00
2025-08-15500CALL0 0404.8FALSE00
2025-08-15200PUT0 0112.5FALSE00
2025-08-15210PUT0 0262.83FALSE00
2025-08-15220PUT0 0231.91FALSE00
2025-08-15230PUT0 0201.51FALSE00
2025-08-15240PUT0 0171.27FALSE00
2025-08-15250.35PUT0 1052.26FALSE00
2025-08-15260.5PUT3 064.05FALSE0.50
2025-08-15271.1PUT0 6691.38TRUE00
2025-08-15281.45PUT3 053.57TRUE1.450
2025-08-15290.9PUT0 5771.73TRUE00
2025-08-15300PUT0 080.88TRUE00
2025-08-15311.29PUT0 089.22TRUE00
2025-08-15324.2PUT0 256.78TRUE00
2025-08-15334.1PUT0 1106.25TRUE00
2025-08-15344.7PUT0 3104.71TRUE00
2025-08-15355.4PUT0 2114.88TRUE00
2025-08-15364.6PUT0 2139.17TRUE00
2025-08-15370PUT0 0149.17TRUE00
2025-08-15380PUT0 0158.76TRUE00
2025-08-15390PUT0 00TRUE00
2025-08-15400PUT0 0400.59TRUE00
2025-08-15410PUT0 0412.95TRUE00
2025-08-15420PUT0 0424.83TRUE00
2025-08-15430PUT0 0436.26TRUE00
2025-08-15440PUT0 1447.28TRUE00
2025-08-15450PUT0 0457.91TRUE00
2025-08-15460PUT0 0468.19TRUE00
2025-08-15470PUT0 0478.14TRUE00
2025-08-15480PUT0 0487.77TRUE00
2025-08-15490PUT0 00TRUE00
2025-08-15500PUT0 0506.17TRUE00
2025-09-19150CALL0 0228.65TRUE00
2025-09-19170CALL0 0192.94TRUE00
2025-09-19180CALL0 0176.64TRUE00
2025-09-19190CALL0 040.22TRUE00
2025-09-19200CALL0 055.76TRUE00
2025-09-19210CALL0 060.19TRUE00
2025-09-19220CALL0 048.03TRUE00
2025-09-19230CALL0 057.1TRUE00
2025-09-19240CALL0 051.84TRUE00
2025-09-19250CALL0 060.58TRUE00
2025-09-19260CALL0 064.72TRUE00
2025-09-19270CALL0 064.37FALSE00
2025-09-19283.9CALL0 365.65FALSE00
2025-09-19291.35CALL1 259.44FALSE1.350
2025-09-19301.19CALL0 369.67FALSE00
2025-09-19311CALL0 273.06FALSE00
2025-09-19322CALL0 277.1FALSE00
2025-09-19332.02CALL0 582.9FALSE00
2025-09-19340.65CALL0 888.23FALSE00
2025-09-19351.2CALL0 1380.23FALSE00
2025-09-19360CALL0 198.64FALSE00
2025-09-19370CALL0 8103.84FALSE00
2025-09-19380CALL0 3108.79FALSE00
2025-09-19390CALL0 6113.52FALSE00
2025-09-19400.8CALL0 18118.05FALSE00
2025-09-19410CALL0 4122.4FALSE00
2025-09-19420CALL0 3126.57FALSE00
2025-09-19430CALL0 2130.6FALSE00
2025-09-19440CALL0 7134.48FALSE00
2025-09-19450.5CALL0 35138.23FALSE00
2025-09-19500CALL0 8155.25FALSE00
2025-09-19550CALL0 7169.97FALSE00
2025-09-19150PUT0 0182.81FALSE00
2025-09-19170PUT0 090.09FALSE00
2025-09-19180PUT0 0139.27FALSE00
2025-09-19190PUT0 1127.39FALSE00
2025-09-19200PUT0 1115.88FALSE00
2025-09-19210PUT0 0105.68FALSE00
2025-09-19220PUT0 197.44FALSE00
2025-09-19230.56PUT10 058.09FALSE0.560
2025-09-19240PUT0 080.74FALSE00
2025-09-19250PUT0 276.59FALSE00
2025-09-19260PUT0 072.61FALSE00
2025-09-19270PUT0 267.19TRUE00
2025-09-19281.9PUT0 364.32TRUE00
2025-09-19290PUT0 254.43TRUE00
2025-09-19301.8PUT0 1853.77TRUE00
2025-09-19312.6PUT0 90652.62TRUE00
2025-09-19323PUT0 3251TRUE00
2025-09-19334.3PUT0 348.93TRUE00
2025-09-19345PUT0 350.55TRUE00
2025-09-19350PUT0 055.14TRUE00
2025-09-19360PUT0 3059.51TRUE00
2025-09-19370PUT0 263.7TRUE00
2025-09-19380PUT0 267.73TRUE00
2025-09-19390PUT0 1151.73TRUE00
2025-09-19409.1PUT0 2156.78TRUE00
2025-09-19410PUT0 1161.64TRUE00
2025-09-19420PUT0 0166.31TRUE00
2025-09-19430PUT0 0170.81TRUE00
2025-09-19440PUT0 3175.14TRUE00
2025-09-19450PUT0 0179.34TRUE00
2025-09-19500PUT0 0198.39TRUE00
2025-09-19550PUT0 0214.91TRUE00
2025-12-19150CALL0 065.48TRUE00
2025-12-19170CALL0 059.97TRUE00
2025-12-19180CALL0 063.24TRUE00
2025-12-19190CALL0 061.26TRUE00
2025-12-19200CALL0 061.38TRUE00
2025-12-19210CALL0 059.3TRUE00
2025-12-19220CALL0 055.61TRUE00
2025-12-192310.2CALL0 158.48TRUE00
2025-12-19240CALL0 051.04TRUE00
2025-12-19255CALL10 2361.56TRUE50
2025-12-19265.7CALL0 655.71TRUE00
2025-12-19273.5CALL5 252.71FALSE3.50
2025-12-19284.5CALL0 1654.97FALSE00
2025-12-19293.73CALL0 2357.72FALSE00
2025-12-19302.35CALL23 2271.94FALSE2.350
2025-12-19313.1CALL0 258.03FALSE00
2025-12-19323.6CALL0 4054.77FALSE00
2025-12-19332CALL1 1160.01FALSE20
2025-12-19342.05CALL0 760.83FALSE00
2025-12-19351.3CALL20 85955.01FALSE1.30
2025-12-19360CALL0 163.67FALSE00
2025-12-19371.95CALL0 464FALSE00
2025-12-19401.29CALL5 2569.16FALSE1.290
2025-12-19450.65CALL0 1177.73FALSE00
2025-12-19500.6CALL0 6685.59FALSE00
2025-12-19551.1CALL0 893.83FALSE00
2025-12-19600.01CALL0 12101.09FALSE00
2025-12-19650.08CALL0 16107.58FALSE00
2025-12-19700CALL0 6113.43FALSE00
2025-12-19750CALL0 1118.76FALSE00
2025-12-19800CALL0 0123.65FALSE00
2025-12-19850CALL0 0128.16FALSE00
2025-12-19900CALL0 0132.36FALSE00
2025-12-19150PUT0 0105.74FALSE00
2025-12-19170.25PUT0 1292.5FALSE00
2025-12-19180.4PUT0 186.55FALSE00
2025-12-19190.55PUT0 180.71FALSE00
2025-12-19200PUT0 476.13FALSE00
2025-12-19210.85PUT0 170.89FALSE00
2025-12-19220PUT0 066.61FALSE00
2025-12-19230PUT0 062.6FALSE00
2025-12-19241.75PUT0 255.63FALSE00
2025-12-19252.05PUT0 659.65FALSE00
2025-12-19261.85PUT0 158.11FALSE00
2025-12-19273.24PUT0 158.35TRUE00
2025-12-19280PUT0 057.14TRUE00
2025-12-19290PUT0 059.61TRUE00
2025-12-19304.2PUT0 856.41TRUE00
2025-12-19314.42PUT0 1058.14TRUE00
2025-12-19324.8PUT0 454.47TRUE00
2025-12-19330PUT0 058.59TRUE00
2025-12-19340PUT0 057.19TRUE00
2025-12-19357.2PUT0 3856.1TRUE00
2025-12-19360PUT0 057.44TRUE00
2025-12-19370PUT0 057.39TRUE00
2025-12-19409.1PUT0 354.07TRUE00
2025-12-19450PUT0 059.08TRUE00
2025-12-19500PUT0 0116.17TRUE00
2025-12-19550PUT0 0125.98TRUE00
2025-12-19600PUT0 0134.68TRUE00
2025-12-19650PUT0 0142.52TRUE00
2025-12-19700PUT0 0149.66TRUE00
2025-12-19750PUT0 0156.21TRUE00
2025-12-19800PUT0 0162.25TRUE00
2025-12-19850PUT0 0167.86TRUE00
2025-12-19900PUT0 0173.1TRUE00
2026-01-16150CALL0 067.87TRUE00
2026-01-162012.3CALL0 1560.47TRUE00
2026-01-16255CALL1 1755.26TRUE50
2026-01-16303.6CALL0 18355FALSE00
2026-01-16353.4CALL0 7156.9FALSE00
2026-01-16403.3CALL0 1763.6FALSE00
2026-01-16451.15CALL0 5371.8FALSE00
2026-01-16501.35CALL0 7579.07FALSE00
2026-01-16551.4CALL0 1185.53FALSE00
2026-01-16601.05CALL0 5191.58FALSE00
2026-01-16650.24CALL0 397.47FALSE00
2026-01-16700CALL0 5102.79FALSE00
2026-01-16750CALL0 0107.64FALSE00
2026-01-16800CALL0 5112.08FALSE00
2026-01-16850CALL0 0116.19FALSE00
2026-01-16900CALL0 0120FALSE00
2026-01-16150PUT0 099.48FALSE00
2026-01-16201.25PUT0 875.81FALSE00
2026-01-16252.5PUT0 1260.84FALSE00
2026-01-16304.5PUT0 656.93TRUE00
2026-01-16357.3PUT0 251.96TRUE00
2026-01-164013.5PUT0 2059.99TRUE00
2026-01-16450PUT0 00TRUE00
2026-01-16500PUT0 0106.98TRUE00
2026-01-16550PUT0 0116.05TRUE00
2026-01-16600PUT0 0124.12TRUE00
2026-01-16650PUT0 0131.39TRUE00
2026-01-16700PUT0 0137.98TRUE00
2026-01-16750PUT0 0144.02TRUE00
2026-01-16800PUT0 0149.6TRUE00
2026-01-16850PUT0 0154.8TRUE00
2026-01-16900PUT0 0159.67TRUE00
2026-03-20208.64CALL2 055.06TRUE8.640
2026-03-20210CALL0 055.47TRUE00
2026-03-20220CALL0 058.15TRUE00
2026-03-20230CALL0 057.01TRUE00
2026-03-20247.3CALL0 559.61TRUE00
2026-03-20250CALL0 057.57TRUE00
2026-03-20260CALL0 059.05TRUE00
2026-03-20270CALL0 056.95FALSE00
2026-03-20280CALL0 058.5FALSE00
2026-03-20295.05CALL0 255.46FALSE00
2026-03-20300CALL0 057.78FALSE00
2026-03-20310CALL0 055.01FALSE00
2026-03-20320CALL0 056.11FALSE00
2026-03-20330CALL0 057.55FALSE00
2026-03-20340CALL0 056.6FALSE00
2026-03-20350CALL0 055.99FALSE00
2026-03-20360CALL0 053.15FALSE00
2026-03-20372.08CALL1 257FALSE2.080
2026-03-20380CALL0 052.8FALSE00
2026-03-20390CALL0 056.39FALSE00
2026-03-20400CALL0 057.05FALSE00
2026-03-20450CALL0 060.76FALSE00
2026-03-20200PUT0 064.02FALSE00
2026-03-20210PUT0 058.9FALSE00
2026-03-20220PUT0 064.62FALSE00
2026-03-20230PUT0 063.39FALSE00
2026-03-20240PUT0 061.8FALSE00
2026-03-20250PUT0 061.54FALSE00
2026-03-20260PUT0 060.88FALSE00
2026-03-20270PUT0 060.78TRUE00
2026-03-20280PUT0 059.71TRUE00
2026-03-20290PUT0 058.91TRUE00
2026-03-20300PUT0 057.77TRUE00
2026-03-20310PUT0 059.32TRUE00
2026-03-20320PUT0 058.15TRUE00
2026-03-20330PUT0 056.03TRUE00
2026-03-20340PUT0 057.31TRUE00
2026-03-20357.1PUT0 3055.14TRUE00
2026-03-20360PUT0 055.93TRUE00
2026-03-20370PUT0 052.92TRUE00
2026-03-20380PUT0 055.36TRUE00
2026-03-20390PUT0 054.67TRUE00
2026-03-20400PUT0 055.29TRUE00
2026-03-20450PUT0 052.63TRUE00

Latest CRNX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST5$17.17
Jun 13, 2022 7:59 PM EST100$17.19
Jun 13, 2022 7:59 PM EST1$17.17
Jun 13, 2022 7:59 PM EST100$17.2
Jun 13, 2022 7:59 PM EST100$17.2

Crinetics Pharmaceuticals, Inc (CRNX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm
2018-07-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1658247/000000000018021079/0000000000-18-021079-index.htm
2019-08-16UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1658247/000000000019012560/0000000000-19-012560-index.htm
2018-09-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000031506618002299/0000315066-18-002299-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000031506619000968/0000315066-19-000968-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000031506620000861/0000315066-20-000861-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019963/0000899243-18-019963-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019964/0000899243-18-019964-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019965/0000899243-18-019965-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019967/0000899243-18-019967-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019968/0000899243-18-019968-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019972/0000899243-18-019972-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019974/0000899243-18-019974-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019975/0000899243-18-019975-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019978/0000899243-18-019978-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318019979/0000899243-18-019979-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm
2019-02-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924319003318/0000899243-19-003318-index.htm
2019-02-125Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924319003326/0000899243-19-003326-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm
2018-07-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000094787118000610/0000947871-18-000610-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000101297518000919/0001012975-18-000919-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm
2018-08-274/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000101297518001046/0001012975-18-001046-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918045567/0001104659-18-045567-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918045579/0001104659-18-045579-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918046292/0001104659-18-046292-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2018-07-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465918048071/0001104659-18-048071-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919006113/0001104659-19-006113-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919008632/0001104659-19-008632-index.htm
2019-02-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919010154/0001104659-19-010154-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465920011470/0001104659-20-011470-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000110465920021136/0001104659-20-021136-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000114420419008307/0001144204-19-008307-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000117266120000650/0001172661-20-000650-index.htm
2018-07-128-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1658247/000119312518216421/0001193125-18-216421-index.htm
2018-07-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312518217820/0001193125-18-217820-index.htm
2018-07-13CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312518217824/0001193125-18-217824-index.htm
2018-07-17S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1658247/000119312518219860/0001193125-18-219860-index.htm
2018-07-18424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1658247/000119312518220701/0001193125-18-220701-index.htm
2018-07-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1658247/000119312518220704/0001193125-18-220704-index.htm
2018-07-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518222517/0001193125-18-222517-index.htm
2018-07-30SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1658247/000119312518231543/0001193125-18-231543-index.htm
2018-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1658247/000119312518259557/0001193125-18-259557-index.htm
2018-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518263610/0001193125-18-263610-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518289506/0001193125-18-289506-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312518325476/0001193125-18-325476-index.htm
2019-08-13S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1658247/000119312519220012/0001193125-19-220012-index.htm
2019-08-19S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1658247/000119312519224488/0001193125-19-224488-index.htm
2019-08-19CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312519224495/0001193125-19-224495-index.htm
2019-08-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1658247/000119312519230761/0001193125-19-230761-index.htm
2020-04-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312520099551/0001193125-20-099551-index.htm
2020-04-14424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1658247/000119312520107151/0001193125-20-107151-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312520107156/0001193125-20-107156-index.htm
2020-04-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000119312520108092/0001193125-20-108092-index.htm
2020-04-15424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1658247/000119312520108096/0001193125-20-108096-index.htm
2020-04-20SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1658247/000119312520111625/0001193125-20-111625-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119018982/0001209191-19-018982-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119018983/0001209191-19-018983-index.htm
2019-03-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119018984/0001209191-19-018984-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038894/0001209191-19-038894-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038896/0001209191-19-038896-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038897/0001209191-19-038897-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038902/0001209191-19-038902-index.htm
2019-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119038905/0001209191-19-038905-index.htm
2019-07-163Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119042285/0001209191-19-042285-index.htm
2019-07-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119042286/0001209191-19-042286-index.htm
2019-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2020-02-115Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120008269/0001209191-20-008269-index.htm
2020-02-115Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120008272/0001209191-20-008272-index.htm
2020-02-115Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120008280/0001209191-20-008280-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120012974/0001209191-20-012974-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120012987/0001209191-20-012987-index.htm
2020-02-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120012997/0001209191-20-012997-index.htm
2020-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120021372/0001209191-20-021372-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038153/0001209191-20-038153-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038161/0001209191-20-038161-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038166/0001209191-20-038166-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038172/0001209191-20-038172-index.htm
2020-06-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2020-09-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120049508/0001209191-20-049508-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000120919120049518/0001209191-20-049518-index.htm
2020-01-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020003601/0001213900-20-003601-index.htm
2020-03-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-06-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000121390020014709/0001213900-20-014709-index.htm
2018-07-12CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1658247/000135445718000250/0001354457-18-000250-index.htm
2018-08-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459018022504/0001564590-18-022504-index.htm
2018-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459018029304/0001564590-18-029304-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019007555/0001564590-19-007555-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1658247/000156459019007561/0001564590-19-007561-index.htm
2019-04-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019011511/0001564590-19-011511-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1658247/000156459019013719/0001564590-19-013719-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1658247/000156459019013723/0001564590-19-013723-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019018827/0001564590-19-018827-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459019018831/0001564590-19-018831-index.htm
2019-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019023431/0001564590-19-023431-index.htm
2019-07-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019025016/0001564590-19-025016-index.htm
2019-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019031797/0001564590-19-031797-index.htm
2019-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459019031801/0001564590-19-031801-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459019042893/0001564590-19-042893-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459019042900/0001564590-19-042900-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000156459020004205/0001564590-20-004205-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020009362/0001564590-20-009362-index.htm
2020-03-0910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1658247/000156459020009365/0001564590-20-009365-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1658247/000156459020019202/0001564590-20-019202-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1658247/000156459020019210/0001564590-20-019210-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020023260/0001564590-20-023260-index.htm
2020-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459020023265/0001564590-20-023265-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020030117/0001564590-20-030117-index.htm
2020-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020038067/0001564590-20-038067-index.htm
2020-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459020038069/0001564590-20-038069-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020042431/0001564590-20-042431-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020044046/0001564590-20-044046-index.htm
2020-10-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020047499/0001564590-20-047499-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1658247/000156459020051684/0001564590-20-051684-index.htm
2020-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1658247/000156459020051686/0001564590-20-051686-index.htm
2018-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000161577418006600/0001615774-18-006600-index.htm
2018-07-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2018-07-26SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1658247/000161577418006903/0001615774-18-006903-index.htm
2019-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1658247/999999999518001811/9999999995-18-001811-index.htm
2019-08-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1658247/999999999519002011/9999999995-19-002011-index.htm

Crinetics Pharmaceuticals, Inc (CRNX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crinetics Pharmaceuticals, Inc (CRNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 450%
Institutional Ownership: 9514%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-185AM Ventures IV, L.P.10% Share HolderSell6,194.0024.25150,208.84104,489.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2019-08-05Richard Scott StruthersPresident & CEOBuy10,000.001.9119,100.001,225,805.00https://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm
2019-12-16Matthew K FustDirectorSell3,500.0022.5078,750.0012,536.00https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2019-01-225AM Ventures IV, L.P.10% Share HolderSell10,486.0021.88229,381.25129,483.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2018-07-205AM Ventures IV, L.P.10% Share HolderBuy4,600.0017.0078,200.00139,969.00https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy141,177.0017.002,400,009.00141,177.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2019-12-16Matthew K FustDirectorBuy3,500.001.916,685.0016,036.00https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2020-03-09Vivo Capital VIII, LLC10% Share HolderSell133.0019.502,593.50168,165.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10Vivo Capital VIII, LLC10% Share HolderSell5,904.0021.40126,345.60168,298.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07Vivo Capital VIII, LLC10% Share HolderSell4,614.0022.00101,508.00174,202.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04Vivo Capital VIII, LLC10% Share HolderSell10,519.0022.80239,833.20178,816.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31Vivo Capital VIII, LLC10% Share HolderSell4,220.0021.7091,574.00189,335.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30Vivo Capital VIII, LLC10% Share HolderSell5,940.0022.10131,274.00193,555.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29Vivo Capital VIII, LLC10% Share HolderSell10,878.0022.20241,491.60199,495.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2018-07-20Alan Seth KrasnerChief Medical OfficerBuy2,000.0017.0034,000.002,000.00https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm
2019-03-20Vivo Capital VIII, LLC10% Share HolderSell83,984.0022.251,868,644.00210,373.00https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2020-04-17Vivo Capital VIII, LLC10% Share HolderSell74,333.0015.401,144,728.202,162,587.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-04-16Vivo Capital VIII, LLC10% Share HolderSell26,527.0015.20403,210.402,236,920.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-04-15Vivo Capital VIII, LLC10% Share HolderSell189,625.0015.502,939,187.502,263,447.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2019-06-215AM Ventures IV, L.P.InsiderSell240,000.0022.205,328,000.002,267,797.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2018-07-20PERCEPTIVE ADVISORS LLCDirectorBuy400,000.0017.006,800,000.002,280,305.00https://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm
2020-04-07Vivo Capital VIII, LLC10% Share HolderSell5,373.0014.2076,296.602,453,072.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-03Vivo Capital VIII, LLC10% Share HolderSell263,600.0013.803,637,680.002,458,445.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2019-03-185AM Ventures IV, L.P.10% Share HolderSell148,645.0024.253,604,745.302,507,797.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2020-03-09Vivo Capital VIII, LLC10% Share HolderSell347.0019.506,766.502,722,045.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10Vivo Capital VIII, LLC10% Share HolderSell1,451.0021.4031,051.402,722,392.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07Vivo Capital VIII, LLC10% Share HolderSell1,134.0022.0024,948.002,723,843.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04Vivo Capital VIII, LLC10% Share HolderSell2,584.0022.8058,915.202,724,977.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31Vivo Capital VIII, LLC10% Share HolderSell1,037.0021.7022,502.902,727,561.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30Vivo Capital VIII, LLC10% Share HolderSell1,459.0022.1032,243.902,728,598.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29Vivo Capital VIII, LLC10% Share HolderSell2,673.0022.2059,340.602,730,057.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2019-03-20Vivo Capital VIII, LLC10% Share HolderSell292,609.0022.256,510,550.252,732,730.00https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy153,180.0020.733,175,421.40294,357.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-04-17Vivo Capital VIII, LLC10% Share HolderSell10,265.0015.40158,081.00298,625.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy51,686.0017.00878,662.003,025,339.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-04-16Vivo Capital VIII, LLC10% Share HolderSell3,663.0015.2055,677.60308,890.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2019-01-225AM Ventures IV, L.P.10% Share HolderSell251,667.0021.885,505,215.633,107,642.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2020-04-15Vivo Capital VIII, LLC10% Share HolderSell26,185.0015.50405,867.50312,553.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2018-07-205AM Ventures IV, L.P.10% Share HolderBuy110,400.0017.001,876,800.003,359,309.00https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2020-04-07Vivo Capital VIII, LLC10% Share HolderSell742.0014.2010,536.40338,738.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-03Vivo Capital VIII, LLC10% Share HolderSell36,400.0013.80502,320.00339,480.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-17PERCEPTIVE ADVISORS LLC10% Share HolderBuy1,071,428.0014.0014,999,992.003,659,381.00https://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm
2020-03-09Vivo Capital VIII, LLC10% Share HolderSell48.0019.50936.00375,880.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10Vivo Capital VIII, LLC10% Share HolderSell200.0021.404,280.00375,928.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07Vivo Capital VIII, LLC10% Share HolderSell157.0022.003,454.00376,128.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04Vivo Capital VIII, LLC10% Share HolderSell357.0022.808,139.60376,285.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31Vivo Capital VIII, LLC10% Share HolderSell143.0021.703,103.10376,642.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30Vivo Capital VIII, LLC10% Share HolderSell201.0022.104,442.10376,785.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29Vivo Capital VIII, LLC10% Share HolderSell369.0022.208,191.80376,986.00https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2019-03-20Vivo Capital VIII, LLC10% Share HolderSell40,407.0022.25899,055.75377,355.00https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-20Vivo Capital VIII, LLC10% Share HolderBuy7,137.0017.00121,329.00417,762.00https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-07-16Richard Scott StruthersPresident & CEOSell17,500.0014.46253,107.75890,805.00https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2020-07-15Richard Scott StruthersPresident & CEOSell17,500.0015.30267,722.00908,305.00https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2019-06-215AM Ventures IV, L.P.InsiderSell10,000.0022.20222,000.0094,489.00https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2020-04-28WENDALL WIERENGADirectorBuy25,329.000.7318,490.1799,846.00https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm